JOGO-Gx, a gadget that uses an artificial intelligence-driven mobile app and wearable sensors to reduce motor symptoms in persons with Parkinson’s disease, has demonstrated early promising results.
JOGO Health, the firm that owns JOGO-Gx, claims that using the device at least twice a week reduced tremors in Parkinson’s patients participating in a clinical study by 70%.
“JOGO-Gx has significantly decreased my tremors. After taking JOGO-Gx before bed, I am able to sleep better. Hugh Fitzpatrick, who has been using JOGO-Gx for approximately a month, claimed in a news release that he no longer needs to take his sleep prescription.
The experiment, which is being carried out in partnership with Parkinson’s People in the United Kingdom, will follow roughly 40 Parkinson’s patients from the United States and the United Kingdom for three months to evaluate their experiences with the device.
“We’re excited to collaborate with JOGO on their pilot study with Parkinson’s patients to explore who could benefit from the JOGO-Gx digital solution. “It’s showing to help ease symptoms like tremors,” said Russ Bradford, co-founder of the Parkinson’s People with his wife Charlotte.
The goal of JOGO-Gx is to improve the ability of the central nervous system (CNS, brain, and spinal cord) to remodel or rewire itself, a notion known as neuroplasticity. This is a key aspect of the brain, since it allows it to restructure its neural pathways, which are enormous networks of tangled circuits that link nerve cells.
The gadget, which is worn on the wrist, does this by using input from muscles and the nerve cells that govern them (motor neurons). Electromyography sensors, which can monitor nerve activity, measure this response.
“Using electromyographic (EMG) biofeedback, JOGO-Gx taps into the intrinsic neuroplasticity of the central nervous system (CNS).” Consider neuroplasticity to be a GPS system. You will be diverted to your destination if there is a traffic delay. “Alternate neural pathways are established in the brain to gain control over afflicted muscles,” explained Gary Krasilovsky, PhD. Krasilovsky is the chief scientific officer of JOGO Health and a neuroplasticity researcher with over 40 years of experience.
“By using biofeedback to instruct the brain to relax, we can help patients naturally manage their tremors.” He went on to say that JOGO-Gx is non-invasive and does not produce any electrical signals.
“We know that patients with Parkinson’s disease need to deal with their symptoms on a personal basis, and JOGO-Gx can help with that.” Bradford noted that the gadget might assist with pain and incontinence, which are two major Parkinson’s symptoms.
“The true advantage would be that JOGO-Gx does not necessitate taking extra medicine, and it may even help individuals lower the medication they’re already taking,” he added.